..."And because these severely blocked places are not in good locations and there are problems such as myocardial bridges, simply implanting stents can no longer solve the problem, so our plan is still to directly perform vascular implantation and bypass surgery to bypass
These severely blocked lesions will directly supply blood to the terminal blood vessels, which will completely solve the blockage problem in these locations.
As we all know, whether it is stent implantation or vascular implantation bypass surgery, it is the most conventional, safest and currently the best treatment option for the treatment of coronary heart disease and myocardial infarction. However, they also bring some problems, such as surgery
Afterwards, long-term use of drugs is required, and long-term use of these drugs will cause some damage to the body, such as damage to liver and kidney function, and long-term use of anticoagulant drugs may cause the patient's platelet count to decrease.
If the patient is injured in this way, it will cause excessive bleeding and the bleeding cannot be stopped in time, which may be life-threatening in severe cases.
Therefore, Mr. Zhang and his family still have some doubts about such a treatment plan. As it happens, we also learned that Haoyu Technology Company has been engaged in research in the field of medical technology and has developed many advanced medical technologies.
And there are experts from the Linghu Medical Research Center of the Affiliated Hospital of Air Force Medical College here, and we also want to hear your opinions and suggestions."
After listening to Director Bai's introduction, Director Tong nodded, and then said: "Your hospital's treatment work is very good. At this stage, it is most important to stabilize the patient's condition and maintain the patient's vital signs.
Judging from your introduction and the relevant examination reports previously transmitted, the patient's condition is not optimistic. The patient's heart has many areas of stenosis, more than a dozen, of which five are the most serious, leading to this myocardial infarction.
There are two places.
We agree with your opinion that stent implantation at this stage cannot completely solve these problems, and vascular implantation and bypass surgery are necessary.
Although the patient's cardiac myocardium is damaged and blood vessels are severely blocked, we still recommend that the patient directly undergo a smart bionic artificial heart implantation surgery until the last moment.
Although the success rate of smart bionic artificial heart implantation is very high, and the patient's postoperative survival treatment is also very good. However, this is an artificial thing after all, and it is naturally not as good as our native heart.
And some research shows that the human heart is also an emotional organ, which can market the patient's personality and emotions to a certain extent. For example, after the completion of many foreign allogeneic heart transplant surgeries, the patient's personality and even some behavioral habits have undergone great changes.
And this change will also be close to the personality of the donor.
Although there are not enough case reports to confirm this research finding, it illustrates a problem. The intelligent bionic artificial heart will certainly not have emotions, but it may also destroy the patient's original emotional personality and behavioral habits to a certain extent.
And this is the last resort to save one's life. Unless it is a last resort, it is never the best choice."
At this point, Director Tong paused for a moment, and then continued: "After relevant discussions, we have a total of three sets of treatment plans.
First of all, the first set of treatment plans is relatively conventional. The first is to use the latest biodegradable stents on the market in our country to implant and expand the narrowed areas of the heart, thereby leading to smooth blood flow in these locations.
The biggest advantage of this biodegradable stent compared to the original metal-coated stent is that it can degrade and melt. It only needs to be implanted into the body, so that after two or three years, these stents will completely degrade and integrate into the blood vessels, and
Form a stable support structure in blood vessels to maintain smooth flow of blood vessels.
Therefore, there will be no situation where the stent remains in the blood vessel and is buried by vascular secretions for life and cannot be removed.
On the basis of this again, we will use bio-3D printing technology to extract the patient’s blood vessel wall cells to print artificial blood vessels, and then use these artificial blood vessels to perform cardiac vascular implantation and bypass surgery for the patient.
And this time we are not answering one or two, but directly establishing a second blood supply channel for the patient's terminal myocardial tissue. In this way, we can increase the blood supply to the terminal myocardial tissue. Even if one blood vessel is narrowed and blocked, there will be another blood vessel.
A blood vessel supplies blood to avoid myocardial infarction and angina pectoris.
In addition, using stem cell therapy, we will conduct stem cell treatment and repair of the patient's myocardial tissue damaged by infarction, thereby restoring the firepower of this part of the myocardial tissue and improving heart function."
At this point, Director Tong glanced at the reactions of everyone in the video screen, and then continued: "This second set of treatment plans is also more thorough, that is, it uses bio-3D printing technology to print out the patient's blockage one by one.
The coronary vascular tissue is then implanted and replaced, so that the patient has a new tubular artery blood supply network.
Because the materials needed to print blood vessels are derived from the patient's own blood vessel wall cells, there will be no rejection reaction. The patient does not need to take medication for life, and the treatment will have significant curative effects.
Of course, this treatment plan also requires the repair of the patient's damaged myocardial tissue, which can be repaired using stem cells or 3D bioprinting technology.
After treatment, the patient's life after recovery is still very good, and he can basically return to normal."
"As for the third set of treatment options, it is more conservative. That is to use stents to implant and expand the blocked blood vessels in the patient's body to ensure the smooth flow of these blood vessels.
We have seen these two myocardial bridges, and it is not necessary to undergo bypass surgery. This problem can be solved through the nanovascular stent developed by Haoyu Technology.
At the same time, on this basis, we can use biological stem cell tissue to repair the patient's damaged vascular tissue and myocardial tissue, thereby restoring heart function.
As for the problem of lifelong medication after surgery, there is a solution to this. The first is to reuse biological agents. This biological agent can replace drugs to play an anticoagulant role. In this way, there will not be too many toxic side effects and it can be used for a long time.
use.
The second method is also very simple. That is to implant micro-robots inside the patient's coronary arteries. The function of these micro-robots is to dilute the vascular network at all times, thereby ensuring the smooth flow of the vascular network."
After listening to Director Tong's introduction, a group of doctors such as Director Bai and Vice President Huang from the Mining Group General Hospital showed expressions of amazement. These three plans were really eye-opening for them, and the benefits
